Hierarchical folding-upon-binding of an intrinsically disordered protein

L Lenette F. Kjaer (CNRS, CEA, IBS) F Francesco S. Ielasi (Institute for Advanced Biosciences (IAB), Structural Biology of Novel Targets in Human Diseases, INSERM U1209, CNRS UMR5309) T Thomas Winbolt (CNRS, CEA, IBS) E Elise Delaforge (CNRS, CEA, IBS) M Maud Tengo (CNRS, CEA, IBS) L Luiza Mamigonian Bessa L Laura Mariño Pérez E Elisabetta Boeri Erba (Université Grenoble Alpes, Commissariat à l’Énergie Atomique et aux Énergies Alternatives, CNRS, Institut de Biologie Structurale) G Guillaume Bouvignies A Andrés Palencia (Institute for Advanced Biosciences (IAB), Structural Biology of Novel Targets in Human Diseases, INSERM U1209, CNRS UMR5309) M Malene Ringkjøbing Jensen (Université Grenoble Alpes, Commissariat à l’Énergie Atomique et aux Énergies Alternatives, CNRS, Institut de Biologie Structurale)

Abstract

Abstract Intrinsically disordered proteins (IDPs) often undergo folding-upon-binding to their partners via short linear motifs, typically 5-15 amino acids in length. However, a significant proportion of IDPs do not adhere to this paradigm but fold upon binding through extended regions comprising multiple molecular recognition elements. For these IDPs, the binding mechanisms and the structural characteristics of their folding intermediates remain poorly understood. Here we unveil hierarchical folding of an IDP as it binds to its partner, exemplified by the disordered signaling effector POSH and the small GTPase Rac1. By combining nuclear magnetic resonance (NMR) spectroscopy and X-ray crystallography, we resolve at atomic resolution how POSH transitions from a fully disordered state to a highly ordered, Rac1-bound conformation through two structurally distinct folding intermediates. The folding of each element is contingent on the successful structuring of the preceding element, highlighting a hierarchical folding-upon-binding mechanism. Our work highlights the potential of targeting folding intermediates and conformational transitions to unlock therapeutic opportunities for IDPs.

Article Details

Volume / Issue Vol. 16, Issue 1
Published November 27, 2025
ISSN 2041-1723
Publisher Nature Portfolio

Journal Info

Nature Communications

Nature Portfolio

ISSN: 2041-1723 Open Access Life Sciences

Authors (11)

L

Lenette F. Kjaer

CNRS, CEA, IBS

F

Francesco S. Ielasi

Institute for Advanced Biosciences (IAB), Structural Biology of Novel Targets in Human Diseases, INSERM U1209, CNRS UMR5309

T

Thomas Winbolt

CNRS, CEA, IBS

E

Elise Delaforge

CNRS, CEA, IBS

M

Maud Tengo

CNRS, CEA, IBS

L

Luiza Mamigonian Bessa

L

Laura Mariño Pérez

E

Elisabetta Boeri Erba

Université Grenoble Alpes, Commissariat à l’Énergie Atomique et aux Énergies Alternatives, CNRS, Institut de Biologie Structurale

G

Guillaume Bouvignies

A

Andrés Palencia

Institute for Advanced Biosciences (IAB), Structural Biology of Novel Targets in Human Diseases, INSERM U1209, CNRS UMR5309

M

Malene Ringkjøbing Jensen

Université Grenoble Alpes, Commissariat à l’Énergie Atomique et aux Énergies Alternatives, CNRS, Institut de Biologie Structurale